Covered recipient · General Payments record
JOHN S DIRKSEN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2023
$3,603.41
- Reported across 267 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $519.20 | 35 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $175.02 | 14 |
| Alkermes, Inc. | $117.43 | 5 |
| IRONSHORE PHARMACEUTICALS INC. | $55.67 | 3 |
| IDORSIA PHARMACEUTICALS US INC | $44.82 | 2 |
| ITI, Inc. | $39.32 | 2 |
| Corium, Inc. | $34.85 | 6 |
| Supernus Pharmaceuticals, Inc. | $34.42 | 2 |
| Tris Pharma Inc | $17.67 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2023 20182019202020212022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $18.66 | 01/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996704709 | CMS |
| AbbVie Inc. | $11.48 | 01/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996704713 | CMS |
| AbbVie Inc. | $16.55 | 02/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996704719 | CMS |
| AbbVie Inc. | $7.96 | 02/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996704723 | CMS |
| AbbVie Inc. | $4.60 | 03/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996704729 | CMS |
| AbbVie Inc. | $7.63 | 03/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996704731 | CMS |
| AbbVie Inc. | $11.28 | 04/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996704737 | CMS |
| AbbVie Inc. | $12.44 | 04/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996704741 | CMS |
| AbbVie Inc. | $12.55 | 05/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996704745 | CMS |
| AbbVie Inc. | $19.70 | 05/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996704751 | CMS |
| AbbVie Inc. | $8.14 | 05/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996704755 | CMS |
| AbbVie Inc. | $11.72 | 06/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996704761 | CMS |
| AbbVie Inc. | $20.20 | 06/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996704765 | CMS |
| AbbVie Inc. | $12.11 | 06/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996704771 | CMS |
| Alkermes, Inc. | $26.92 | 01/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022807241 | CMS |
| Alkermes, Inc. | $16.57 | 02/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022807243 | CMS |
| Alkermes, Inc. | $28.51 | 03/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022807245 | CMS |
| Alkermes, Inc. | $20.12 | 04/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022807247 | CMS |
| Alkermes, Inc. | $25.31 | 05/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022807249 | CMS |
| Corium, LLC | $2.59 | 01/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 978040347 | CMS |
| Corium, LLC | $3.77 | 02/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 978040357 | CMS |
| Corium, LLC | $15.92 | 03/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 978194791 | CMS |
| Corium, LLC | $3.77 | 04/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 978040367 | CMS |
| Corium, LLC | $5.03 | 05/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 978040373 | CMS |
| Corium, LLC | $3.77 | 05/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 978519201 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $22.54 | 02/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034527307 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $22.28 | 03/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034527313 | CMS |
| Ironshore Pharmaceuticals Inc. | $16.52 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060510629 | CMS |
| Ironshore Pharmaceuticals Inc. | $19.55 | 05/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060510849 | CMS |
| Ironshore Pharmaceuticals Inc. | $19.60 | 06/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060510757 | CMS |
| ITI, Inc. | $18.48 | 03/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040516300 | CMS |
| ITI, Inc. | $20.84 | 05/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040516305 | CMS |
| Supernus Pharmaceuticals, Inc. | $15.86 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1053236897 | CMS |
| Supernus Pharmaceuticals, Inc. | $18.56 | 04/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1053236903 | CMS |
| Tris Pharma Inc | $17.67 | 05/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059368507 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.